News

Coface SA Reports Current Voting Rights and Shares Count

Coface SA Reports Current Voting Rights and Shares Count

Coface SA Updates on Voting Rights and Total Shares

In a recent announcement, Coface SA provided an essential update regarding the total number of voting rights and shares in its capital structure. Understanding these details is crucial for investors and stakeholders alike, reinforcing the company's commitment to transparency and governance.

Current Share Capital Overview

As of the end of October 2024, Coface SA's share capital stands at an impressive €300,359,584, divided among 150,179,792 shares. Each of these shares is fully paid and corresponds to the same class, ensuring equality among shareholders.

Total Number of Shares

The total number of shares calculated is significant. With 150,179,792 total shares, investors can ascertain their stake in the company easily. This information helps in evaluating the influence they hold regarding corporate decisions.

Insight into Voting Rights

Coface SA reported that the theoretical number of voting rights mirrors the total shares, being also 150,179,792. However, the real number of voting rights accounts for shares not held by the company itself, resulting in a total of 149,420,056. This distinction underscores the importance of understanding how ownership impacts corporate governance.

The Role of Technology in Transparency

To assure stakeholders of the accuracy of their disclosures, Coface SA has employed blockchain technology in documenting regulated information. This ensures unparalleled security and authenticity. Stakeholders can verify the accuracy of disclosures through an accessible platform, enhancing trust in the company’s communications.

Coface's Corporate Structure

Coface SA is structured as a société anonyme, governed under French law with a clear and defined Board of Directors. The company operates under strict regulations defined by the French Commercial Code, showcasing its commitment to ethical business practices.

Registered Office Details

The registered office of Coface SA is located at 1 Place Costes et Bellonte, 92270 Bois Colombes in France. This central location reflects the company's significant presence in the French market.

Importance of Regulated Information

Regulated documents concerning Coface SA are safeguarded with innovative blockchain technologies, ensuring authenticity and security of vital corporate information. Investors and interested parties are encouraged to explore these documents to stay informed about the company’s dealings.

Accessing Company Information

For those looking for Further information, Coface SA maintains an easily navigable website where all necessary details regarding investments, shares, and corporate announcements are readily available. This assists investor decision-making and provides transparency in various business dealings.

Company Listing and Stock Information

Coface SA is traded on Euronext Paris under compartment A, with the ISIN code FR0010667147. The stock symbol that investors look for is COFA. This listing signifies the company's robust stature in the financial markets.

Frequently Asked Questions

What is Coface SA's total number of shares?

Coface SA currently has a total of 150,179,792 shares issued in its capital.

How many voting rights does Coface SA have?

The theoretical number of voting rights is also 150,179,792, but the actual voting rights number is 149,420,056.

What is the share capital amount of Coface SA?

The share capital of Coface SA is €300,359,584, fully paid and subscribed.

How does Coface ensure the integrity of its disclosures?

Coface uses blockchain technology to authenticate and secure its regulated documents, allowing for transparency and ease of verification.

On what exchange is Coface SA listed?

Coface SA is listed on Euronext Paris with the ticker symbol COFA.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

GM Ditches NYSE for Nasdaq: What to Expect?

Updated Category News Views 159

The Big Migration: GM Moves to Nasdaq You know when an old dog changes its turf, it's looking for some new tricks. General Motors (NYSE: GM) has decided to pack its bags and leave the New York Stock Exchange (NYSE) for the Nasdaq Global Select Market. They’re sticking with the same ticker, "GM," but you can expect that big switcheroo come November 17, 2026. I can't be...

Continue Reading
Implantica's Strategic U.S. Entry with RefluxStop®

Updated Category News Views 102

Implantica's Ambitious Move into the U.S. Market Every now and then, a move in the medtech sector grabs everyone's attention, and that's what we got with Implantica's latest play. This company is pulling out the big guns to push its RefluxStop® device into the U.S. market—one of the toughest nuts to crack. They've roped in Dr. John C. Lipham, a leading U.S. surgeon, to...

Continue Reading
Gildan Faces Investor Class Action After Stock Tumbles

Updated Category News Views 15

Shake-Up at Gildan: Investors Take Legal Action Gildan Activewear Inc. (NYSE:GIL) got themselves in hot water, folks. They've landed on the wrong side of an investor class action lawsuit after claims of shady business tactics sent their stock plummeting like a rock in June. We're talking about an 18.75% nosedive here. That's not just a slip—it's a fall worth wearing a...

Continue Reading
Lektra Unveils EdgeStart: Green Earnings from AI

Updated Category News Views 31

AI and Solar Power: A New Revenue Stream Lektra's fresh off the blocks with EdgeStart, an AI server pushing building owners to make a buck off their idle solar power. These self-contained, 8-GPU NVIDIA cabinets don't just sit pretty; they’re money-makers, potentially turning an overlooked asset into a goldmine. If your building's solar panels are just loafing about...

Continue Reading
New Navy Contract Boosts X-Bow's Defense Portfolio

Updated Category News Views 77

Will X-Bow's CHAOS contract shake up defense? Ever get the feeling you're watching a scrappy upstart quietly transform an industry? That's the buzz around X-Bow Systems Inc (X-Bow®) as they announce a partnership with CoAspire for the U.S. Navy's CHAOS program. This ain't just another contract; it's a cornerstone moment for them. So, what's fueling the excitement?...

Continue Reading
Nakama's AniBiz Gains Power with New Investments

Updated Category News Views 12

Anime Titans Back AniBiz Think of the anime sector with a new sheriff in town, and its name is AniBiz.com. This platform, a brainchild of Nakama, Inc., just landed strategic investments from some heavyweight players in the anime world: TBS Group, Toei Animation, and TV TOKYO Holdings. The Significance of Strategic Support Ain’t no small potatoes here. We're talking the...

Continue Reading
KROMATID Joins CIRM's Genomic Analysis Initiative

Updated Category News Views 6

New Partnership Opens Doors for Genomic Mastery In a world where biotechnology races to meet the needs of modern medicine, KROMATID's recent nod as an Industry Resource Partnership (IRP) member, courtesy of the California Institute for Regenerative Medicine (CIRM), makes some noise worth noting. This membership isn't just a feather in their cap—it's their ticket to...

Continue Reading
Ultrasound Innovations: 2D, 3D, and 4D Explained

Updated Category News Views 24

Diving into the World of Ultrasound Imaging When you're in the trenches of expecting a new family member, the last thing you want is to get bogged down in technical jargon that doesn't make a lick of sense. Enter prenatal ultrasound imaging: 2D, 3D, and 4D. Each of these has a specific role in piecing together the puzzle of fetal development. Now, Erika Lambright, a...

Continue Reading
ASSA ABLOY Breaks Records in Q3 2026 Report

Updated Category News Views 35

Another Record Quarter for ASSA ABLOY Well, look who’s breaking records and not just fixing locks. ASSA ABLOY is strutting out of Q3 2026 with numbers worth a double take. The company, based in Stockholm, has reported record sales with a 7% bump, now standing at SEK 40,771 million. Organic growth accounts for a healthy 4%, and if you’re eyeballing where the muscle...

Continue Reading
Navigating Home Care: What Families Need to Know

Updated Category News Views 31

Peeking into the Home Care Playbook The process of starting home care isn't some mind-boggling puzzle. For families in Northeastern Pennsylvania, things kick off with a cordial chinwag with a care coordinator—no paperwork chains or Kafkaesque contracts right off the bat. Now, if you've got someone in need of care, this gives you time to shove all your questions onto the...

Continue Reading

Top 5 Most Recently Viewed Articles

Transform Your Investment: What $1,000 Could Mean Today

Updated Category News Views 30

Transform Your Investment Journey with Booking Holdings Investing in the stock market can feel like a daunting task, yet some companies have proven to be extraordinarily rewarding over the years. One such company is Booking Holdings (NASDAQ: BKNG), which has delivered spectacular returns to its investors. Over the past two decades, its annualized return has outstripped...

Continue Reading
Mirantis Excels in Container Management: 2024 Gartner Recognition

Updated Category News Views 181

Mirantis Recognized as a Challenger by Gartner Mirantis recently announced with pride that it has been named a Challenger in the 2024 Gartner Magic Quadrant for Container Management. This esteemed recognition highlights Mirantis alongside prominent companies such as AWS, Google, and Microsoft. It reflects Mirantis' commitment to giving organizations exceptional control...

Continue Reading
SolarBank Secures $1.5 Million for Innovative EV Charger Projects

Updated Category News Views 172

The Big Picture: EV Charging Initiatives SolarBank has thrown its hat into the ring by applying for $1.5 million in grants for three fast EV charger projects. Now, these aren’t just any chargers; they’re positioned to be pivotal in SolarBank's evolving narrative as a frontrunner in the clean energy sector. The significance here? They’re not merely seeking...

Continue Reading
Nature's Way Unveils Exciting Sambucus Ultra Immune Chews

Updated Category News Views 151

Nature's Way Introduces Innovative Immune Support Chews Building on its award-winning Sambucus brand, Nature's Way presents a delightful new format that transforms immune support into a fun experience. The recently launched Sambucus Ultra Immune Juicy Burst is designed not just to support immune health but to do so in a tasty, enjoyable way that everyone can appreciate. A...

Continue Reading
Getinge's Hemopro 3 Boosts Endoscopic Vessel Harvesting

Updated Category News Views 8

Getinge's Latest Evolution in Endoscopic Vessel Harvesting Witnessing Getinge's launch of the Vasoview Hemopro 3 feels like catching the climax of a meticulous medical drama. This Swedish giant is pushing the envelope in coronary artery bypass grafting (CABG) procedures with this state-of-the-art Endoscopic Vessel Harvesting (EVH) System. For insiders in the healthcare...

Continue Reading